SE7700946L - Klavulansyrationetrar - Google Patents

Klavulansyrationetrar

Info

Publication number
SE7700946L
SE7700946L SE7700946A SE7700946A SE7700946L SE 7700946 L SE7700946 L SE 7700946L SE 7700946 A SE7700946 A SE 7700946A SE 7700946 A SE7700946 A SE 7700946A SE 7700946 L SE7700946 L SE 7700946L
Authority
SE
Sweden
Prior art keywords
acidations
clavulanic
group
beta
ester
Prior art date
Application number
SE7700946A
Other languages
English (en)
Other versions
SE441359B (sv
Inventor
R J Ponsford
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3892/76A external-priority patent/GB1574906A/en
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of SE7700946L publication Critical patent/SE7700946L/sv
Publication of SE441359B publication Critical patent/SE441359B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
SE7700946A 1976-01-31 1977-01-28 Forfarande for framstellning av nya klavulansyratioetrar SE441359B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3892/76A GB1574906A (en) 1976-01-31 1976-01-31 Therapeutic compounds containing - lactams
GB1900276 1976-05-08

Publications (2)

Publication Number Publication Date
SE7700946L true SE7700946L (sv) 1977-08-01
SE441359B SE441359B (sv) 1985-09-30

Family

ID=26238678

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7700946A SE441359B (sv) 1976-01-31 1977-01-28 Forfarande for framstellning av nya klavulansyratioetrar

Country Status (31)

Country Link
US (2) US4428958A (sv)
JP (1) JPS5295689A (sv)
AR (3) AR214306A1 (sv)
AT (1) AT351675B (sv)
AU (1) AU515736B2 (sv)
BG (1) BG27751A3 (sv)
CA (1) CA1089471A (sv)
CH (2) CH637655A5 (sv)
CS (1) CS196341B2 (sv)
DD (1) DD128196A5 (sv)
DE (1) DE2702954A1 (sv)
DK (1) DK146940C (sv)
ES (1) ES455404A1 (sv)
FI (1) FI63581C (sv)
FR (1) FR2339616A1 (sv)
GR (1) GR62544B (sv)
HK (1) HK69883A (sv)
IE (1) IE44759B1 (sv)
IL (1) IL51267A (sv)
KE (1) KE3303A (sv)
LU (1) LU76668A1 (sv)
MX (1) MX4950E (sv)
NL (1) NL7700892A (sv)
NO (1) NO770279L (sv)
NZ (1) NZ183117A (sv)
PH (1) PH13924A (sv)
PT (1) PT66071B (sv)
RO (1) RO69712A (sv)
SE (1) SE441359B (sv)
SU (1) SU645583A3 (sv)
YU (1) YU10777A (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
GB2004541B (en) * 1977-09-16 1982-05-12 Beecham Group Ltd Ethers of clavulanic acid a process for their preparation and pharmaceutical compositions containing them
DE2963679D1 (en) * 1978-09-05 1982-11-04 Beecham Group Plc Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them
EP0018203B1 (en) * 1979-04-21 1983-03-02 Beecham Group Plc Clavulanic acid derivatives, their preparation and use in pharmaceutical compositions
NZ193687A (en) * 1979-05-17 1982-12-21 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
ZA804670B (en) * 1979-08-03 1981-07-29 Beecham Group Ltd Derivatives of clavulanic acid, a process for their preparation and their use
NZ199061A (en) * 1980-12-09 1984-10-19 Beecham Group Ltd 9-(n-tetrazolyl)-deoxyclavulanic acids,salts,esters,and pharmaceutical compositions
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds
US5958462A (en) * 1997-05-23 1999-09-28 Mclean; Linsey Therapeutic bath salts and method of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039673A (en) 1973-10-30 1977-08-02 Bayer Aktiengesellschaft Penicillins and cephalosporins and their production
US3983113A (en) 1975-08-15 1976-09-28 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials

Also Published As

Publication number Publication date
PT66071B (en) 1978-06-23
FI63581B (fi) 1983-03-31
CA1089471A (en) 1980-11-11
DK146940C (da) 1984-07-30
LU76668A1 (sv) 1977-06-28
KE3303A (en) 1983-08-05
NO770279L (no) 1977-08-02
NL7700892A (nl) 1977-08-02
AU2177077A (en) 1978-08-03
AR216555A1 (es) 1979-12-28
BG27751A3 (bg) 1979-12-12
YU10777A (en) 1982-06-30
SE441359B (sv) 1985-09-30
IE44759L (en) 1977-07-31
CS196341B2 (en) 1980-03-31
CH638529A5 (de) 1983-09-30
IL51267A (en) 1979-12-30
AR214306A1 (es) 1979-05-31
ES455404A1 (es) 1978-05-01
FR2339616B1 (sv) 1980-04-11
AR216925A1 (es) 1980-02-15
DD128196A5 (de) 1977-11-02
RO69712A (fr) 1980-07-15
PH13924A (en) 1980-11-04
IE44759B1 (en) 1982-03-24
DK146940B (da) 1984-02-20
ATA53477A (de) 1979-01-15
MX4950E (es) 1983-01-12
PT66071A (en) 1977-02-01
FI770295A7 (sv) 1977-08-01
DK38577A (da) 1977-08-01
HK69883A (en) 1983-12-23
NZ183117A (en) 1979-10-25
US4428958A (en) 1984-01-31
DE2702954A1 (de) 1977-08-04
JPS5295689A (en) 1977-08-11
FI63581C (fi) 1983-07-11
US4505894A (en) 1985-03-19
CH637655A5 (de) 1983-08-15
FR2339616A1 (fr) 1977-08-26
GR62544B (en) 1979-05-07
IL51267A0 (en) 1977-03-31
SU645583A3 (ru) 1979-01-30
AT351675B (de) 1979-08-10
JPS613349B2 (sv) 1986-01-31
AU515736B2 (en) 1981-04-30

Similar Documents

Publication Publication Date Title
SE7504999L (sv) Cefalosporiner med -acylaminoettiksyrasidokedja.
ES459785A1 (es) Un procedimiento para la preparacion de nuevos esteres anti-bacterianos.
SE8401134D0 (sv) Forfarande for framstellning av dihydro-cyklosporin d
IT7825205A0 (it) Processo per l'ossidazione di composti aromatici sostituiti ad acidi carbossilici aromatici
IE852229L (en) Penicillin compounds
NO904377D0 (no) Tricykliske karbapenemforbindelser.
SE7611047L (sv) Forfarande for framstellning av antibakteriella emnen
AT367764B (de) Verfahren zur herstellung von neuen cephalosporin-derivaten
ES455404A1 (es) Un procedimiento para la preparacion de nuevos derivados de beta-lactama.
ES497872A0 (es) Un procedimiento mejorado de oxidacion de un compuesto organico.
SE7904731L (sv) Nya l-leucyl-4-hydroxianilidderivat
SE7709071L (sv) Olivansyraestrar
GR77088B (sv)
IE44295L (en) Preparation of clavulanic acid
GB1493197A (en) Amides of clavulanic acid
JPS5690088A (en) Novel cephalosporin analog compound
ES8101603A1 (es) Un procedimiento para la preparacion de derivados de penici-lina o de cefalosporina
IE44192L (en) 1-aza-4-oxabicyclo [3,2,0] heptene compounds
SE7503274L (sv) Cefalosporin
US4100178A (en) 4,5-Didehydro-6-methoxy-2-arylmethoxymethyl-4α-tetrahydropyranacetic acid alkyl esters
US4100177A (en) 4,5-Didehydro-6-hydroxy-2-arylmethoxymethyl-4α-tetrahydropyranacetic acid alkyl esters
GB2001531A (en) Organic compounds
US4100176A (en) 4,5-Didehydro-6-hydroxy-2β-arylmethoxymethyl-4α-tetrahydropyranacetic acids
ES470902A1 (es) Procedimiento para la obtencion de un nuevo derivado cefa- losporanico
GB2004273A (en) beta -Lactam compounds, preparation and use

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7700946-2

Effective date: 19870915

Format of ref document f/p: F